DEA schedule
Is bumetanide a controlled substance?
Federal schedule for bumetanide from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Bumetanide is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bumetanide is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted bumetanide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 127 prescription listings from 40 labelers, none with a DEA schedule |
| DEA controlled substances list | bumetanide is not on the list |
Bumetanide NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 30698-630 | Bumex | tablet | .5 mg/1 | Validus Pharmaceuticals LLC | None |
| 30698-631 | Bumex | tablet | 1 mg/1 | Validus Pharmaceuticals LLC | None |
| 30698-632 | Bumex | tablet | 2 mg/1 | Validus Pharmaceuticals LLC | None |
| 84388-005 | Enbumyst | spray | .5 mg/.1mL | Corstasis USA LLC | None |
| 0641-6284 | Bumetanide | injection | .25 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0641-6285 | Bumetanide | injection | .25 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 31722-368 | Bumetanide | injection | .25 mg/mL | Camber Pharmaceuticals, Inc. | None |
| 31722-369 | Bumetanide | injection | .25 mg/mL | Camber Pharmaceuticals, Inc. | None |
| 51662-1449 | BUMETANIDE | injection | .25 mg/mL | HF Acquisition Co LLC, DBA HealthFirst | None |
| 55154-1527 | Bumetanide | injection | .25 mg/mL | Cardinal Health 107, LLC | None |
| 55154-5131 | Bumetanide | injection | .25 mg/mL | Cardinal Health 107, LLC | None |
| 65219-570 | Bumetanide | injection | .25 mg/mL | Fresenius Kabi USA, LLC | None |
| 65219-572 | Bumetanide | injection | .25 mg/mL | Fresenius Kabi USA, LLC | None |
| 67184-0593 | Bumetanide | injection | .25 mg/mL | Qilu Pharmaceutical Co., Ltd. | None |
| 67184-0594 | Bumetanide | injection | .25 mg/mL | Qilu Pharmaceutical Co., Ltd. | None |
| 68083-496 | Bumetanide | injection | .25 mg/mL | Gland Pharma Limited | None |
| 68083-497 | Bumetanide | injection | .25 mg/mL | Gland Pharma Limited | None |
| 68462-469 | Bumetanide | injection | .25 mg/mL | GLENMARK PHARMACEUTICALS INC., USA | None |
| 68462-470 | Bumetanide | injection | .25 mg/mL | GLENMARK PHARMACEUTICALS INC., USA | None |
| 70748-323 | BUMETANIDE | injection | .25 mg/mL | Lupin Pharmaceuticals, Inc. | None |
| 72162-2632 | Bumetanide | injection | .25 mg/mL | Bryant Ranch Prepack | None |
| 72162-2633 | Bumetanide | injection | .25 mg/mL | Bryant Ranch Prepack | None |
| 72205-101 | Bumetanide | injection | .25 mg/mL | Novadoz Pharmaceuticals LLC | None |
| 72205-102 | Bumetanide | injection | .25 mg/mL | Novadoz Pharmaceuticals LLC | None |
| 72572-040 | Bumetanide | injection | .25 mg/mL | Civica, Inc. | None |
| 72572-041 | Bumetanide | injection | .25 mg/mL | Civica, Inc. | None |
| 83301-0080 | Bumetanide | injection | .25 mg/mL | Mullan Pharmaceutical Inc. | None |
| 83301-0081 | Bumetanide | injection | .25 mg/mL | Mullan Pharmaceutical Inc. | None |
| 0641-6007 | Bumetanide | injection, solution | .25 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 0641-6008 | Bumetanide | injection, solution | .25 mg/mL | Hikma Pharmaceuticals USA Inc. | None |
| 25021-321 | Bumetanide | injection, solution | .25 mg/mL | Sagent Pharmaceuticals | None |
| 72572-210 | Bumetanide | injection, solution | .25 mg/mL | Civica, Inc. | None |
| 72572-211 | Bumetanide | injection, solution | .25 mg/mL | Civica, Inc. | None |
| 83854-007 | Bumetanide | injection, solution | .25 mg/mL | Anthea Pharma Private Limited | None |
| 83854-035 | Bumetanide | injection, solution | .25 mg/mL | Anthea Pharma Private Limited | None |
| 0185-0128 | Bumetanide | tablet | .5 mg/1 | Sandoz Inc | None |
| 0615-8614 | Bumetanide | tablet | .5 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 0781-8099 | Bumetanide | tablet | .5 mg/1 | Sandoz Inc | None |
| 16571-679 | Bumetanide | tablet | .5 mg/1 | Rising Pharma Holdings, Inc | None |
| 23155-900 | bumetanide | tablet | .5 mg/1 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
Showing 40 of 127 listings.
Questions
Is bumetanide a controlled substance?
No. Bumetanide is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and bumetanide is not on the DEA controlled substances list.
Is bumetanide a narcotic?
No. Bumetanide is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Loop Diuretic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.